BRAF and cancer: Similar to the metabolic effects of BRAF inhibition, DCA switches glycolytic cancer cells away from glycolysis towards mitochondrial respiration [9, 38, 39], but unlike PLX4032, the effect of DCA is not limited to BRAF-mutated melanomas [29].